Matched-Pair Comparison of

18F-rhPSMA-7 68Ga-PSMA-11 PET prostate cancer prostate-specific membrane antigen (PSMA) radiohybrid PSMA (rhPSMA)

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
01 08 2021
Historique:
received: 11 06 2020
accepted: 12 11 2020
pubmed: 6 12 2020
medline: 6 1 2022
entrez: 5 12 2020
Statut: ppublish

Résumé

Radiohybrid prostate-specific membrane antigen (rhPSMA) ligands are a new class of prostate cancer theranostic agents.

Identifiants

pubmed: 33277394
pii: jnumed.120.251447
doi: 10.2967/jnumed.120.251447
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1082-1088

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Markus Kroenke (M)

Institute of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, Munich, Germany.
Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Lilit Mirzoyan (L)

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Thomas Horn (T)

Department of Urology, School of Medicine, Technical University of Munich, Munich, Germany.

Jan C Peeken (JC)

Department of Radiation Oncology, School of Medicine, Technical University of Munich, Munich, Germany.
Institute of Radiation Medicine, Department of Radiation Sciences, Helmholtz Zentrum München, Neuherberg, Germany; and.

Alexander Wurzer (A)

Pharmaceutical Radiochemistry, School of Medicine, Technical University of Munich. Munich, Germany.

Hans-Jürgen Wester (HJ)

Pharmaceutical Radiochemistry, School of Medicine, Technical University of Munich. Munich, Germany.

Marcus Makowski (M)

Institute of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, Munich, Germany.

Wolfgang A Weber (WA)

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Matthias Eiber (M)

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Isabel Rauscher (I)

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany; isabel.rauscher@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH